

Most Read This Week
- Neoadjuvant–Adjuvant vs Adjuvant-Only Pembrolizumab for Advanced Melanoma
- Nicotinamide for Skin Cancer Chemoprevention in Transplant Recipients
- Efficacy of Alisertib Alone vs Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
- Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients
Recently Updated
- Mailed Human Papillomavirus Self-Sampling Kits Are Cost-Effective
- Slight Increase in Breast Cancer Risk Seen With Progestogen-Only Contraceptives
- Minimal Residual Disease Negativity Predicts Time to Next Treatment in Multiple Myeloma
- Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients
- Urothelial Cancer Prediction Model Has High Sensitivity, Specificity